Two bidders make the cut in Bulgarian IFV programme
Proposals from General Dynamics European Land Systems (GDELS) and Patria have been downselected for the second phase of the Bulgarian 8x8 IFV procurement programme.
The Bulgarian MoD selected the Patria AMVxp (pictured) and GDELS-Mowag Piranha V vehicles, preferring them to the Nexter VBCI and ARTEC Boxer.
Shephard Defence Insight notes that the Bulgarian Army has a long-standing requirement to replace legacy Soviet-era equipment, with a high priority given to procuring 90 new 8x8 IFVs to equip four battalion-sized battle groups, for an estimated cost of BGN896 million ($540 million).
After several delays, the Bulgarian MoD issued an RfP in August 2018 to the four downselected bidders mentioned above.
A winner should have been selected in December that year before a contract announcement in early 2020. However, this was delayed amid the COVID-19 pandemic.
As part of our promise to deliver comprehensive coverage to our Defence Insight and Premium News subscribers, our curated defence news content provides the latest industry updates, contract awards and programme milestones.
Related Programmes in Defence Insight
Related Equipment in Defence Insight
More from Land Warfare
-
![Australia and Singapore open expanded training area in Queensland]()
Australia and Singapore open expanded training area in Queensland
Australia and Singapore have expanded Queensland’s Shoalwater Bay Training Area (SWBTA), adding advanced facilities and technologies to support larger, longer joint military exercises under their ongoing strategic partnership.
-
![Lockheed Martin to increase PAC-3 MSE production by 70%]()
Lockheed Martin to increase PAC-3 MSE production by 70%
The company manufactured 380 missiles in 2023 and plans to build 650 missiles per year from 2027.
-
![Canadian tech firm makes promise to increase precision and longevity of weapons]()
Canadian tech firm makes promise to increase precision and longevity of weapons
Supplied by Paradigm Shift, EPVD technology has undergone trials with the US and Canadian services.
